This review will focus on the role of kinases in regulating HTT phosphorylation, one of the most important PTM in regulating HTT toxicity, and their potential as therapeutic targets, with special emphasis on Protein kinase CK2, an emergent therapeutic target for the treatment of various neurodegenerative diseases including HD. Here, WEE1 is linked to Huntington disease.